(a) The program administrator, directly or through a university-affiliated foundation, may solicit funds from business, industry, foundations, research organizations, federal government agencies, individuals, and other private sources for the purpose of administering the program and awarding grants to increase patient access to clinical trials targeting cancer, consistent with guidelines established by the board.
(b) (1) Subject to paragraph (2), only funds from federal or private sources may be used to administer the program or award grants.
(2) The university may use its own state source funds for oversight and administration of the program relating to the initial start-up costs of the program only, provided the university is reimbursed from federal or private sources of funds.
(Amended by Stats. 2017, Ch. 561, Sec. 126. (AB 1516) Effective January 1, 2018.)
Last modified: October 25, 2018